Alkayyali, T. Et Al. 2020. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. ACTA DIABETOLOGICA , vol.57, no.5 , 613-618.

Alkayyali, T., Qutranji, L., Kaya, E., Bakir, A., & YILMAZ, Y., (2020). Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. ACTA DIABETOLOGICA , vol.57, no.5, 613-618.

Alkayyali, Tasnim Et Al. "Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease," ACTA DIABETOLOGICA , vol.57, no.5, 613-618, 2020

Alkayyali, Tasnim Et Al. "Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease." ACTA DIABETOLOGICA , vol.57, no.5, pp.613-618, 2020

Alkayyali, T. Et Al. (2020) . "Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease." ACTA DIABETOLOGICA , vol.57, no.5, pp.613-618.

@article{article, author={Tasnim Alkayyali Et Al. }, title={Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease}, journal={ACTA DIABETOLOGICA}, year=2020, pages={613-618} }